FDA Recall Terminated

MY01 Continuous Compartmental Pressure Monitor, Reference Number MY01-0001

Recall: Z-2384-2021 · Initiated June 28, 2021

Recall

Recall Number
Z-2384-2021
Event Number
88396
FEI Number
3017398927
Product Code
LXC
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
June 28, 2021
Terminated
July 25, 2022
Address
MY01 INC. 400 De Maisonneuve Blvd W, Montreal Canada Suite 700

Description

MY01 Continuous Compartmental Pressure Monitor, Reference Number MY01-0001

Reason

There is an incorrect version of the needle in the introducer part of devices. The affected Lots were manufactured using needles with a needle trocar geometry which is out of specification and may require a slightly higher push force from the user to penetrate the patient skin.

Action

A Medical Device Advisory Notice dated 6/28/21 was sent to customers. Clinicians Responsibilities/ Actions required: 1. Review this notification for awareness of the contents 2. Identify and quarantine any unused affected products in your inventory for return to MY01 Inc. Contact Customer Success team by phone (+1 (855) 292-6901) or email ([email protected]) to arrange for your replacements. 3. There are no specific patient monitoring instructions related to this voluntary product removal that are recommended beyond your existing follow up schedule. 4. Complete Attachment 1- Certificate of acknowledgement and email to [email protected] by 07-Jul-2021. 5. Include a copy of Attachment 1- Certificate of acknowledgement with product to be returned. Please use the return shipping label (to be provided by MY01 Inc.), please return affected product to: Regulatory Affairs and Quality Management MY01 Inc. 400 Maisonneuve Boulevard West, Suite 700, Montreal, Quebec, Canada H3A 1L4 6. Retain a copy of this document and Attachment 1- Certificate of acknowledgement with your records. 7. If you have further questions or concerns after reviewing this notice, please call the customer service team at 1-855-292-6901. Alternatively, your questions may be emailed to: [email protected] Under 21 CFR 803, manufacturers are also required to report any serious injuries where a product has contributed or may have contributed to the event. Please keep MY01 Inc. informed of any adverse events associated with this by emailing [email protected] or call +1(855)-292-6901.

Distribution

US Nationwide distribution in the states of MD, OH, CA, NY.

Quantity

37 units